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Summary 
VAMP is a synaptic vesicle membrane protein required 
for fusion. Synaptic vesicle targeting was measured 
for mutants of an epitope-tagged form of VAMP in 
transfected PC12 cells. A signal within a predicted am- 
phipathic a helix is essential for targeting to synaptic 
vesicles. Cellubrevin, a nonneural VAMP homolog, 
contains this signal and is also targeted to synaptic 
vesicles. Amino acid substitutions within the synaptic 
vesicle targeting signal either enhance or inhibit sort- 
ing of VAMP to synaptic vesicles, but do not affect the 
ability of VAMP to form complexes with syntaxin and 
SNAP-25. 
Introduction 
Synaptic vesicles have a unique collection of membrane 
proteins required for storage of neurotransmitters and reg- 
ulated exocytosis (Bennett and Scheller, 1994). After fu- 
sion with the plasma membrane, synaptic vesicles are re- 
cycled within the nerve terminal by endocytosis of synaptic 
vesicle membranes proteins (Holtzman et al., 1971). Sig- 
nificant progress has been made in the identification of 
functional interactions made by synaptic vesicle proteins 
during the processof regulated fusion (Bennett and Scheller, 
1994). However, little is known about how proteins are 
targeted to synaptic vesicles. A high degree of sorting 
fidelity is required for synaptic vesicle biogenesis to ensure 
that each synaptic vesicle contains enough copies of each 
essential protein. Since they have a diameter of only 50 
nm, synaptic vesicles must form by a single budding event 
and have space for only 80 polypeptides of an average 
molecular mass of 50 kDa (Jahn and Stidhof, 1993). Self- 
association of synaptic vesicle membrane proteins under 
appropriate conditions could promote high fidelity sorting 
(Bennett et al., 1992). Neuroendocrine-specific adapta- 
tions of the cytoplasmic budding machinery may also be 
required. 
One approach to understanding how proteins are tar- 
geted to synaptic vesicles is to identify signals within a 
synaptic vesicle protein required for proper targeting. No 
candidate targeting signals have been identified by com- 
paring amino acid sequences of the known synaptic vesi- 
cle membrane proteins. Therefore, it was necessary to 
take a systematic approach to identifying a synaptic vesi- 
cle targeting signal. VAMP, also known as synaptobrevin, 
was chosen for this search because of its low molecular 
mass and its topological simplicity compared with other 
synaptic vesicle membrane proteins. VAMP is an 18 kDa 
protein attached to the cytoplasmic face of synaptic vesi- 
cles by a C-terminal transmembrane anchor (Trimble, 
1993). Two VAMP isoforms have been cloned from a vari- 
ety of species. These isoforms have a highly conserved 
region in their cytoplasmic domain adjacent to the trans- 
membrane anchor. The conserved region is predicted to 
contain two amphipathic a helices (Dascher et al., 1991). 
Helix 1, from amino acids 39 to 53, is unusually hydropho- 
bic and may interact with lipidsduring the process of mem- 
brane fusion (Jahn and Sudhof, 1994). Helix 2, from amino 
acids 60 to 88, is of sufficient length to be predicted to 
interact with a similar amphipathic helix on another protein 
in a coiled-coil structure (Lupas et al., 1991). 
VAMP-2, the isoform expressed in PC12 cells, is impli- 
cated in synapticvesicle fusion, since it is the unique target 
on synaptic vesicles for tetanus neurotoxin (Schiavo et 
al., 1992). Tetanus toxin-poisoned nerve terminals are 
defective in neurotransmitter secretion and accumulate 
synaptic vesicles that are associated with the presynaptic 
plasma membrane, but cannot fuse (Hunt et al., 1994). In 
detergent extracts, VAMP-2 is found in a complex with 
two neural-specific plasma membrane proteins, syntaxin 1 
and synaptosome-associated protein of 25 kDa (SNAP-25) 
(Siillner et al., 1993b). This complex is known as a SNAP 
receptor, or SNARE, because it serves as an assembly site 
for two components of the intracellular fusion machinery, 
a-SNAP and NSF. SNARE complexes are formed by the 
interaction between a V-SNARE on a transport vesicle and 
a t-SNARE on its fusion target. It has been suggested that 
the interaction between V-SNARES and t-SNARES pro- 
vides specificity for membrane fusion (Sollner et al., 
1993a). The assembly of SNARE complexes in vivo is reg- 
ulated by Rab proteins that may contribute additional 
specificity to vesicle fusion (Brennwald et al., 1994; Se- 
gaard et al., 1994). Although VAMP is located primarily 
in synaptic vesicles, homologous proteins may act as 
V-SNARES in other membrane fusion processes. For ex- 
ample, cellubrevin, a protein involved in the fusion of endo- 
somal recycling vesicles with the plasma membrane, 
shares97% identitywith VAMP-2 in the conserved domain 
(McMahon et al., 1993). In addition, there are proteins 
more distantly related to VAMP that function as V-SNARES 
in yeast and are required for secretion (Protopopov et al., 
1993). 
PC12 cells are a model system for the study of synaptic 
vesicle membrane protein traffic. Although they do not 
form synapses, undifferentiated PC12 cells contain synap- 
tic vesicle-like vesicles (also known as synaptic-like mi- 
crovesicles) that share many features with authentic syn- 
aptic vesicles (Wiedenmann et al., 1988; Clift-D’Grady et 
al., 1990; Cameron et al., 1991; Linstedt and Kelly, 1991). 
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Figure 1. Primary Structure of VAMP-TAg 
(A) Schematic representation of VAMP-TAg and mutants. The cyto- 
plasmic domain of VAMP-2 consists of an N-terminal variable domain 
and a conserved domain containing two predicted amphipathic a heli- 
ces. To create VAMP-TAg, we appended an eight amino acid epitope 
from the SV40 T antigen, via a 14 amino acid spacer, to the C-terminus 
of the transmembrane anchor. Two large N-terminal deletions and 
a chimera containing the transmembrane domain of the transferrin 
receptor were constructed to identify targeting domains. A third mu- 
tant, A2-31-TfR-TM, contains the conserved domain of VAMP fused 
to the transmembrane domain of the transferrin receptor and the epi- 
tope tag. 
(6) Sequence of the conselved domain of VAMP-TAg. Amino acids 
on the hydrophobic face of the two predicted amphipathic a helices 
are indicated in bold type. 
In particular, PC12 synaptic vesicles contain all of the 
known synaptic vesicle membrane proteins, including 
VAMP and synaptophysin. These proteins recycle be- 
tween synaptic vesicles and the plasma membrane. The 
transferrin receptor (TfR) recycles between endosomes 
and the plasma membrane, but is excluded from synaptic 
vesicles. 
By studying the effects of cis mutations on the mem- 
brane transport of VAMP in transfected PC12 cells, we 
have identified a signal required for synaptic vesicle tar- 
geting that may also have a fundamental role in V-SNARE 
function. Point mutations within this signal can either en- 
hance or inhibit sorting to synaptic vesicles. 
Results 
Epitope-Tagged VAMP Is Targeted to Endosomes 
and Synaptic Vesicles 
Since mutations in VAMP that affect its targeting might 
also destroy epitopes required for detection, an epitope- 
tagged version of VAMP (VAMP-TAg) was constructed. 
An eight amino acid epitope from the C-terminus of the 
simian virus 40 (SV40) T antigen was appended, via a 
13 amino acid spacer sequence, to the C-terminus of rat 
VAMP-2 to create VAMP-TAg (Figure 1A). The KT3 mono- 
clonal antibody (MAb) binds to this C-terminal T antigen 
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Figure 2. Synaptic Vesicle Targeting of VAMP-TAg in PC12 Cells 
(A) Cosedimentation of VAMP-TAg with synaptic vesicles on a glycerol 
gradient. Cells were homogenized, and a postnuclear supernatant 
was sedimented into a glycerol gradient with a 50% sucrose cushion. 
Gradient fractions were immunoblotted with the SVP-38 (anti-synap- 
tophysin) and 10.1 (anti-VAMP) MAbs. The unidentified low molecular 
mass band may result from cross reaction of the 10.1 antibody with 
cellubrevin. The synaptic vesicle peak is found in lanes 8-l 1. Endo- 
somes containing synaptic vesicle proteins accumulate on the sucrose 
pad in lanes l-4. 
(6) Internalization of [?]KT3 to recycled synaptic vesicles. VAMP-TAg 
PC12 cells were incubated with [1251]KT3 for 1 hr at 37%. A synaptic 
vesicle enriched supernatant from a homogenate of washed cells was 
sedimented into a glycerol gradient, and [‘251]KT3 radioactivity (closed 
squares) was counted in gradient fractions. Synaptophysin immunore- 
activity (open circles) was measured by an enzyme-linked immuno- 
assay. 
epitope (MacArthur and Walter, 1984). VAMP-TAg cDNA 
was transfected into PC12 cells, and a clonal cell line was 
selected for targeting studies. 
Synaptic vesicle targeting was examined by sedimen- 
tation of a synaptic vesicle enriched supernatant from 
VAMP-TAg PC1 2 cells on a glycerol gradient. After centrif- 
ugation, synaptic vesicles are found in a peak midway 
through the gradient, while larger membranous organ- 
elles, including all endosomal organelles containing inter- 
nalized transferrin, sediment to the bottom of the gradient 
and can be collected on a 50% sucrose cushion (Clift- 
D’Grady et al., 1990). Gradient fractions were analyzed 
by immunoblotting with antibodies against the synaptic 
vesicle membrane proteins synaptophysin and VAMP. As 
expected, VAMP-TAg cosedimented with synaptophysin 
and VAMP-P, indicating that it is targeted to synaptic vesi- 
cles (Figure 2A). CHO cells do not have synaptic vesicles 
(Clift-O’Grady et al., 1990). Thus, no peak of VAMP-TAg 
in small vesicles was detected in a homogenate from 
transfected CHO cells analyzed on a glycerol gradient 
(data not shown). 
The synaptic vesicles of PC12 cells recycle by endo- 
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Figure 3. The Conserved Domain of VAMP Is Necessary and Suffi- 
cient for Synaptic Vesicle Targeting 
(A) Domain mapping mutants. 
(6) Targeting of A2-31-TfR-TM and cellubrevin. A synaptic vesicle 
enriched supernatant from a homogenate of PC12 cells transfected 
with each construct was sedimented into a glycerol gradient without 
a sucrose pad. Gradient fractions were immunoblotted with KT3 (anti- 
TAg) or anti-cellubrevin antibodies. The higher molecular mass form 
of the A2-31-TfR-TM mutant, which is not targeted to synaptic vesi- 
cles, was consistently observed. 
cytosis (Clift-O’Grady et al., 1990). This recycling was ob- 
served by incubating VAMP-TAg PC1 2 cells in media con- 
taining iodinated KT3. After a 1 hr incubation at 37%, 
[1z51]KT3 was internalized to a peakof vesicles cosediment- 
ing with synaptophysin on a glycerol gradient (Figure 28). 
As expected, [‘251]KT3 was not internalized to synapticves- 
icle-sized vesicles in nontransfected PC1 2 cells or in 
VAMP-TAg transfected CHO cells (data not shown). 
[‘251]KT3-loaded vesicles from a glycerol gradient peak 
were immunoadsorbed to beads coated with anti-synapto- 
physin antibodies to determine whether VAMP-TAg and 
synaptophysin are in the same vesicle. After stringent 
washing, 75% of the [1z51]KT3 counts per minute remained 
bound to anti-synaptophysin-coated beads, whereas less 
than 2% bound specifically to anti-TfR beads. Larger en- 
dosomal organelles containing [lZ51]KT3 bound to both 
anti-synaptophysin and anti-TfR-coated beads (L. Clift- 
O’Grady and Ft. B. K., unpublished data). Thus, the peak 
of internalized [‘?]KT3 in small vesicles was sorted to 
synaptophysin-containing synaptic vesicles and away 
from endosomal vesicles of the TfR recycling pathway. 
A Conserved Domain Is Sufficient for Synaptic 
Vesicle Targeting 
To identify targeting signals, we transiently transfected 
mutant VAMP-TAg cDNAs into PC1 2 cells by electropora- 
tion. Two large N-terminal deletions (A2-31 and 82-60) 
and a chimera (TfR-TM), in which the transmembrane do- 
main of VAMP-TAg was replaced with the transmembrane 
domain of the TfR, were constructed to identify the do- 
mains that contain signals required for synaptic vesicle 
targeting (see Figure 1A). A2-31 and TfR-TM sedimented 
with synaptic vesicles on glycerol gradients (Figure 3A). 
Therefore, the N-terminal variable domain and the trans- 
membrane domain are not required for synaptic vesicle 
targeting. A2-60 was not targeted to synaptic vesicles, 
indicating that amino acids 32-60 are required for synaptic 
vesicle targeting. 
Endocytosis of the VAMP-TAg mutants was measured 
to determine whether synaptic vesicle recycling was dis- 
rupted by loss of an endocytosis signal. The rate of inter- 
nalization was measured by binding [1Z51]KT3 to cells at 
4%, warming to 37% for various times, and then measur- 
ing the fraction of [?]KT3 resistant to acid stripping. The 
endocytosis rate was not significantly diminished by either 
of the N-terminal deletions or by replacement of the trans- 
membrane domain (data not shown). Thus, the A2-60 mu- 
tation inhibits synaptic vesicle targeting, but not endocyto- 
sis. Since the synaptic vesicle targeting signal can be 
removed without significantly reducing uptake of label 
from the surface, the majority of internalized VAMP-TAg 
must be targeted to an alternate destination, presumably 
endosomes. 
A fourth mutant, VAMP-TAg cDNA (A2-31-TfR-TM), 
was constructed to determine whether the conserved do- 
main of VAMP-TAg is sufficient for synaptic vesicle tar- 
geting. This mutant contains the conserved domain of 
VAMP-2 in a chimeric protein with the transmembrane 
domain of the transferrin receptor and the epitope tag (see 
Figure 1 A). A2-31 -TfR-TM was targeted to synaptic vesi- 
cles, as expected based on the results from its component 
mutations (Figure 38). 
Cellubrevin is 97% identical to VAMP-2 throughout the 
conserved domain, including the 29 amino acid sequence 
required for targeting VAMP-TAg to synaptic vesicles. The 
results from the VAMP-TAg deletions and chimeras sug- 
gest that cellubrevin should be targeted to synaptic vesi- 
cles. To test this prediction, we overexpressed cellubrevin 
in PC12 cells. A peak of cellubrevin was observed cosedi- 
menting with synapticvesicles, confirming that the domain 
conserved between VAMP and cellubrevin is sufficient for 
synaptic vesicle targeting (Figure 38). 
Fine Mapping of the Synaptic Vesicle 
Targeting Signal 
To localize targeting signals more precisely, we con- 
structed a series of internal deletions within the conserved 
domain of VAMP-TAg. Cell surface antibody binding was 
measured to ensure that none of the mutants was retained 
in the secretory pathway owing to gross structural defects 
or the absence of a signal required for transport to the cell 
surface (data not shown). PC1 2 cells transfected with each 
internal deletion mutant were analyzed by sedimentation 
through glycerol gradients to measure synaptic vesicle 
targeting. The synaptic vesicle peak fractions were pooled 
from each gradient and analyzed on adjacent lanes of the 
same gel to facilitate comparisons among the mutants 
(Figure 4A). Total membrane protein from each homoge- 
nate was analyzed on a second gel to show the expression 
levels of the mutants. Two mutants, A31-36 and A41-50, 
were not targeted to synaptic vesicles. Unexpectedly, there 
were also two mutants, A61-70 and A71-80, that exhibited 
enhanced targeting to synaptic vesicles. After correction 
for expression and the yield of synaptic vesicles (see Ex- 
perimental Procedures), the recovery of A61-70 in synap- 
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tic vesicles is 50 times greater than that of VAMP-TAg, 
while that of A4150 was only 6% of VAMP-TAg (Figure 48). 
The A41-50 mutant lacks the central portion of helix 1 
(see Figure 1 B). Since this mutant was defective for both 
synaptic vesicle targeting and endocytosis (see below), 
the targeting signal in helix 1 was further defined by mutat- 
ing each amino acid from 41 to 50 individually to Ala. Tar- 
geting of the Ala scanning mutants to synaptic vesicles 
was analyzed as described above (Figures 4C and 4D). 
Substitution of Ala for Met46 or any of the bulky hydropho- 
bic amino acids in helix 1 blocked synaptic vesicle tar- 
geting. By contrast, substitutionof Alafor Asn-49orAsp-44 
led to an increase in synaptic vesicle targeting. Thus, 
amino acids throughout helix 1 are involved in the synaptic 
vesicle targeting signal. In general, the extent of synaptic 
vesicle targeting correlates with the hydrophobicity of 
helix 1. 
Increased Sorting to Synaptic Vesicles 
There are two classes of mutations that increased the 
amount of VAMP-TAg recovered in synapticvesicles: dele- 
tions within helix 2 that moved helix 1 closer to the trans- 
membrane domain and substitutions that decreased the 
hydrophilicity of helix 1. Because synaptic vesicles are 
dynamicorganelles that continuously fuse with the plasma 
membrane and recycle by endocytosis, the recovery of 
a VAMP-TAg mutant in synaptic vesicles could increase 
either by an increase in sorting of the mutant to synaptic 
vesicles or by a decline in the consumption of synaptic 
vesicles containing the mutant. If, for example, a mutant 
in VAMP-TAg acted as a dominant inhibitor of synaptic 
vesicle exocytosis, synaptic vesicles containing the mu- 
tant would accumulate. However, this accumulation would 
be undetectable in transiently transfected cells because 
Figure 4. Identification of the Synaptic Vesicle 
Targeting Signal 
(A) Synaptic vesicle targeting of mutant VAMP- 
TAg proteins with internal deletions in the con- 
served domain. A synaptic vesicle enriched su- 
pernatant from a homogenate for each mutant 
was sedimented into a glycerol gradient, and 
the synaptic vesicle peak was collected. For 
comparison, total membrane proteins were iso- 
lated by a Triton X-l 14 detergent phase extrac- 
tion from an aliquot of homogenate. Synaptic 
vesicle pools and total membrane proteins 
were immunoblotted with the KT3 and SVP-313 
MAbs. 
(B) Quantification of synaptic vesicle targeting 
for the internal deletion mutants. A synaptic 
vesicle targeting index was developed to com- 
pare quantitatively the synaptic vesicle tar- 
geting efficiency of each mutant with VAMP- 
TAg. The index incorporates corrections for 
variations in expression level and synaptic ves- 
icle yield. 
(C) Synaptic vesicle targeting of Ala scanning 
mutations within helix 1. Synaptic vesicle pools 
and total membrane proteins were prepared as 
described above. 
(D) Quantification of synaptic vesicle targeting 
for the Ala scanning mutants. 
most cells in the population do not express the transfected 
protein. Therefore, a clonal cell line that expressed the 
A61-70 mutant was constructed. The increased recovery 
of A61-70 in synaptic vesicles was reproduced in the cell 
line, but there was no increase in the yield of synaptophy- 
sin in the synaptic vesicle peak (Figure 5A). Assuming that 
the amount of synaptophysin per synaptic vesicle remains 
constant, this result indicates that expression of 861-70 
does not cause an accumulation of synaptic vesicles. 
To determine whether A61 -70 is sorted to synaptic vesi- 
cles more efficiently than VAMP-TAg, we compared trans- 
port of antibody bound to the epitope tag from the cell 
surface to synaptic vesicles between cell lines expressing 
VAMP-TAg and A61-70 (Figure 5B). Cells were incubated 
in [?]KT3 for 1 hr prior to homogenization and fraction- 
ation of organelles on a sedimentation gradient. The frac- 
tion of total cell-associated radioactivity recovered in the 
synaptic vesicle peak was greater for the A61-70 mutant 
than for VAMP-TAg. No change was observed in the up- 
take of the fluid phase tracer horseradish peroxidase to 
synaptic vesicles (data not shown). This indicates that the 
exocytosislendocytosis cycle of synaptic vesicles is not 
blocked by the mutant VAMP. Therefore, A61 -70 is sorted 
to synaptic vesicles more efficiently than VAMP-TAg. 
Distinct Requirements for Synaptic Vesicle 
Targeting and SNARE Complex Formation 
The conserved domain of VAMP is required for formation 
of SNARE complexes (Chapman et al., 1994; Hayashi et 
al., 1994) as well as for synaptic vesicle targeting. To 
determine the relationship between these two processes, 
we characterized the interaction between mutant VAMP- 
TAg proteins and the t-SNARES (Figure 6). Purified soluble 
forms of VAMP, syntaxin, and SNAP-25 were mixed and 
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Figure 5. Increased Targeting of A61-70 to Synaptic Vesicles 
(A) Absence of synaptic vesicle accumulation in A61-70 PC12 cells. 
Synaptic vesicle targeting was measured as in Figure 4D. The amount 
of synaptophysin in synaptic vesicles is unaffected by the A61-70 mu- 
tant VAMP-TAg in a clonal population of transfected PC12 cells. 
(B) Increased transport of A61-70 from the cell surface to synaptic 
vesicles. VAMP-TAg and A61-70 PC12 cells were incubated with 
[‘“IJKTS for 1 hr at 37°C. A synaptic vesicle enriched supernatant 
from a homogenate of washed cells was sedimented into a glycerol 
gradient, and [““l]KTS radioactivity was counted in gradient fractions 
as in Figure 28. 
incubated overnight prior to separation on an SDS-poly- 
acrylamide gel. When samples were not boiled prior to 
electrophoresis, three SDS-resistant complexes were ob- 
served migrating at 55,110, and 220 kDa (Figure 6A; Hay- 
ashi et al., 1994). Each complex is immunoreactive for 
VAMP, syntaxin, and SNAP-25 (data not shown). Deletion 
of helix 1 blocked formation of the SDS-resistant SNARE 
complexes, indicating that helix 1 participates in the inter- 
action between VAMP and the t-SNARES. However, sub- 
stitution of Ala for Met-46 or Asn-49 did not block formation 
of the stable SDS-resistant complexes. 
SNARE complexes were also isolated by immunopre- 
cipitation from PC12cells transfected with VAMP-TAg mu- 
tants to determine whether the potential interactions ob- 
served with purified proteins also occur in cell extracts. 
Both VAMP-TAg and VAMP-2 precipitated in SNARE com- 
plexes from Triton X-lOO-solublized extracts of transfected 
PC12 cells using antibodies to syntaxin and SNAP-25 (Fig- 
ure 66). Mutations of VAMP-TAg had similar effects on 
SNARE complex formation in PC12 extracts and in vitro. 
In particular, the Met-46+Ala and Asn49-Ala point muta- 
tions did not disrupt SNARE complex formation. Since 
these mutations have opposing effects on targeting 
VAMP-TAg to synaptic vesicles, but are still able to form 
high affinity SNARE complexes, the effect of the mutations 
on targeting cannot be an indirect effect of changes in the 
B 
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Figure 6. SNARE Complex Formation by Mutant VAMP-TAg Proteins 
(A) Formation of SDS-resistant SNARE complexes from bacterially 
expressed components. Purified cytoplasmic domains of mutant 
VAMP proteins were incubated overnight with syntaxin and SNAP-25. 
Samples were divided into two aliquots, one of which was boiled for 
3 min, and then each sample was loaded onto an SDS-polyacrylamide 
gel. An immunoblot was prepared and probed with antibodies against 
VAMP. Temperature-sensitive complexes containing all three 
SNARES are identified (markers A, B, and C). The position of molecular 
mass standards is indicated (in kilodaltons). The soluble cytoplasmic 
domain of VAMP (sVAMP) migrates as an 11 kDa monomer V, VAMP- 
TAg; A, A41-50; M, Met-46+Ala; N, Asn-49+Ala. 
(8) lmmunoprecipitation of mutant SNARE complexes from transfected 
PC12 cells. SNARE complexes were immunoprecipitated from Triton 
X-100 lysates of VAMP-TAg-transfected PC12 cells using antibodies 
against syntaxin and SNAP-25. Abbreviations: T, one-tenth fraction 
of total lysate; s, anti-syntaxin immunoprecipitate; S, anti-SNAP-25 
immunoprecipitate. 
ability of VAMP-TAg to interact with syntaxin and SNAP- 
25. Furthermore, coprecipitiation of the Met-46-Ala mu- 
tant in a SNARE complex indicates that VAMP does not 
need to be targeted to synaptic vesicles to associate with 
t-SNARES. 
Discussion 
We have identified a signal required for targeting a mem- 
brane protein to synaptic vesicles. This signal requires 
hydrophobic amino acids within a predicted amphipathic 
helix in the conserved domain of VAMP. An internal dele- 
tion (A41-50) within this helix, which we call helix 1, 
strongly inhibits synaptic vesicle targeting in transfected 
PC12 cells. Other synaptic vesicle membrane proteins do 
not have predicted amphipathic helices with the character- 
istics of helix 1. Thus, it is unlikely that there is a single 
sorting receptor responsible for targeting all synaptic vesi- 
cle proteins. Although there may be distinct sorting recep- 
tors for different classes of synaptic vesicle proteins, we 
favor the alternative possibility that VAMP is targeted to 
synaptic vesicles by associating, via helix 1, with a self- 
assembling complex of synaptic vesicle proteins. The syn- 
aptic vesicle budding machinery may bind to only one com- 
ponent of this complex. 
The synaptic vesicle targeting signal of VAMP is con- 
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served not only in neuronal VAMP isoforms, but also in 
cellubrevin, a V-SNARE for recycling endosomes. Conse- 
quently, cellubrevin was targeted to synaptic vesicles 
upon overexpression in PC12 cells. Similarly, our results 
indicate that a significant fraction of VAMP-TAg in trans- 
fected PC12 cells is targeted to recycling endosomes, 
since a large fraction of endocytosed antibody is released 
into the medium during a chase without being transported 
through synaptic vesicles (E. G., unpublished data). We 
suggest that vesicles targeted for fusion with the plasma 
membrane may incorporate any available plasma mem- 
brane-specific V-SNARE. According to this model, the rel- 
ative abundance of VAMP in synaptic vesicles results not 
from selective intracellular targeting, but from the high 
expression of VAMP in neuronal tissues. In addition, 
VAMP and cellubrevin do not uniquely identify synaptic 
vesicles and recycling endosomes and thus cannot be 
entirely responsible for either differential targeting or fu- 
sion of the two organelles. 
Enhanced Targeting to Synaptic’Vesicles 
A novel feature of the synaptic vesicle targeting signal is 
that mutations can enhance, as well as inhibit, recovery 
of VAMP in synaptic vesicles. An analysis of PC12 cells 
stably expressing the A61-70 mutant indicated that en- 
hanced recovery of mutant VAMP-TAg in synaptic vesicles 
results not from an increase in the number of synaptic 
vesicles, but from an increase in sorting to synaptic vesi- 
cles. If VAMP is sorted to synaptic vesicles by binding to 
a synaptic vesicle protein complex, mutations that change 
the affinity of VAMP-TAg for other synaptic vesicle proteins 
will alter its sorting efficiency. Thus, the A61-70 and Asn- 
49-Ala mutations may increase sorting to synaptic vesicles 
by increasing the affinity of VAMP-TAg for the complex. 
Conversely, mutations that disrupt helix 1 or decrease its 
hydrophobicity may decrease the affinity such that VAMP- 
TAg either fails to associate with the complex or dissoci- 
ates before synaptic vesicle recycling is complete. Since 
mutations can both enhance and inhibit synaptic vesicle 
targeting of VAMP-TAg, a delicate balance in the effi- 
ciency of VAMP targeting to synaptic vesicles seems to 
be required. This balance may be important to allow VAMP 
to cycle between synaptic vesicles and the plasma mem- 
brane. If the interaction of VAMP with the synaptic vesicle 
targeting protein is too strong, VAMP may be unable to 
dissociate to participate in membrane fusion. Conversely, 
if VAMP is not targeted to synaptic vesicles because it 
cannot bind tightly enough to the targeting protein, its fu- 
sion activity will be wasted. 
Protein-Protein Interactions That Might 
Influence VAMP Targeting 
Much of the current interest in VAMP was stimulated by the 
discovery that VAMP forms a complex with the t-SNARES, 
syntaxin, and SNAP-25 (Siillner et al., 1993a). The region 
of VAMP required for binding to syntaxin and SNAP-25 has 
recently been localized to the conserved domain, amino 
acids 24-96 (Hayashi et al., 1994). Consistent with these 
results, deletion of the synaptic vesicle targeting signal in 
helix 1 (A41-50) inhibited coprecipitation of VAMP-TAg 
with the t-SNARES. However, the Met-46-Ala and Asn- 
49+Ala mutants, which have strong but opposite effects 
on synaptic vesicle targeting, did not block SNARE com- 
plex formation. Therefore, the interaction between VAMP 
and the t-SNARES does not modulate the efficiency of 
synaptic vesicle targeting. 
The identity of the protein with which VAMP interacts via 
helix 1 to promote synapticvesicle targeting is unknown. If 
sorting occurs by association with another synapticvesicle 
protein, synaptophysin is an attractive candidate, since 
it is closely associated with VAMP in synaptic vesicles 
(Calakos and Scheller, 1994; Edelmann et al., 1995). How- 
ever, there are indications that the VAMP-synaptophysin 
interaction is not involved in synaptic vesicle targeting. 
The VAMP-synaptophysin interaction occurs in rat brain 
synaptic vesicles, but is not well preserved in PC12 cells 
(Johnston and Siidhof, 1990; Calakos and Scheller, 1994; 
E. G., unpublished data). Furthermore, although the helix 
1 targeting signal is hydrophobic, the VAMP-synaptophy- 
sin interaction is likely to be hydrophilic, since it can be 
disrupted by incubation in 300 mM NaCl (Edelmann et al., 
1995). Synaptotagmin is another synaptic vesicle protein 
that may be involved in VAMP targeting. Synaptotagmin 
is associated with the SNARE complex prior to being dis- 
placed by a-SNAP (Sbllner et al., 1993b) and has been 
proposed to be a regulator of synaptic vesicle recycling, 
since it contains a high affinity-binding site for the AP-2 
adaptors of clathrin-coated pits (Zhang et al., 1994). Addi- 
tional experiments will be required to identify the proteins 
that bind to VAMP via helix 1. 
A Multifunctional Targeting Signal 
Helix 1 is required for VAMP-TAg synaptic vesicle tar- 
geting in PC12 cells. This sequence is also highly con- 
served in cellubrevin, a V-SNARE that is expressed primar- 
ily in cells that lack synaptic vesicles. Therefore, helix 1 
must function in some capacity in nonneuronal cells. One 
possibility is that helix 1 targetsv-SNARES tootherspecial- 
ized compartments derived from endosomes (Herman et 
al., 1994). An alternative possible function is suggested by 
the unusual hydrophobicityof thesignal (Jahn and Siidhof, 
1994). The similarly hydrophobic amphipathic helices of 
some viral envelope proteins act as fusion peptides. These 
peptides intercalate into the lipid bilayer of cellular mem- 
branes and are thought to stimulate fusion by promoting 
close apposition of membranes (White, 1992). Hydropho- 
bic peptides are insoluble in an aqueous environment. 
To circumvent this insolubility, the fusion peptide of the 
influenza hemagglutinin protein is sequestered within a tri- 
mer interface until it is exposed prior to fusion by an ir- 
reversible pH-induced conformational shift. The helix 1 
domain of VAMP may also be sequestered prior to its par- 
ticipation in synaptic vesicle fusion. However, since VAMP 
cycles between synaptic vesicles and the plasma mem- 
brane, it cannot participate in irreversible interactions. A 
solution to this problem would be for helix 1 to bind revers- 
ibly to a hydrophobic region on another synaptic vesicle 
protein. This interaction could simultaneously mask the hy- 
drophobic peptide and target VAMP to synaptic vesicles. 
$aptic Vesicle Targeting Signal 
Conclusions 
The data presented here imply a lack of specificity for 
V-SNARES in associating with proteins that will recycle 
between the plasma membrane and endocytotic vesicles. 
The targeting of a V-SNARE will therefore depend on the 
targeting information in the proteins with which it associ- 
ates. Alterations in the interactions between VAMP and 
proteins at the cell surface or in synaptic vesicles change 
the subcellular distribution of VAMP. Conversely, screen- 
ing mutations for aberrant subcellular localization allows 
the protein associations of VAMP to be studied in a physio- 
logical setting. 
Experimental Procedures 
Cell Culture and Transfectlon 
PC12 (KB) cells were grown in DME H-21 media supplemented with 
10% horse serum, 5% fetal calf serum, 100 U/ml penicillin, and 100 
mglml streptomycin in a humidified 37OC incubator with 10% Con. 
Electroporation was found to be the most efficient method for transfec- 
tion of PC12 cells (Muller et al., 1990). Cells were collected from a 
confluent 15 cm dish in electroporation buffer (137 mM NaCI, 5 mM 
KCI, 0.7 mM Na2HP04, 6 mM dextrose, 20 mM HEPES [pH 7.051) 
pelleted, and resuspended in 650 ul of electroporation buffer. Plasmid 
DNA was added to the resuspended cells. The amount of DNA was 
varied between 40 ng and 300 ng to equalize expression levels. After 
a 10 min incubation at 25’C, the PC12 cells were pulsed in 0.4 cm 
cuvettes with a BTX-300 electroporator set to 500 pF and 230 mV. 
For CHO cells, the settings were 250 nF and 300 mV. The cells were 
transferred to 20 ml of growth media supplemented with 3 mM EGTA 
for 30 min at 37OC to recover from the shock of electroporation and 
then spun down and plated on a 15 cm dish. For transient assays, 
the day after transfection the cells were refed with growth media sup 
plemented with 6 mM sodium butyrate. Butyrate induces expression 
from viral promoters by preventing the deacetylation of histones. Ex- 
periments were carried out on cells 22-24 hr after butyrate addition. 
For the generation of stable PC12 cell lines, cells were diluted onto 
10 cm dishes 3 days after transfection and subjected to selection in 
500 mglml (active) G418 (GIBCO) for approximately 3 weeks until 
resistant colonies appeared. Cell lines were screened by [‘251]KT3 sur- 
face binding and immunoblotting. 
D’Grady et al. (1990). Cells from a confluent 15 cm dish were washed, 
collected, pelleted, and resuspended in 500 pl of buffer A (150 mM 
NaCI, 0.1 mM MgCI,, 1 mM EGTA, 10 mM HEPES [pH 7.41) at 4OC 
and then homogenized by nine passes through a ballbearing cell 
cracker with a nominal clearance of 8 urn. The homogenate was di- 
vided into 400 ug aliquots that were brought up to 150-200 ul in buffer 
A (approximately a I:2 dilution). Postnuclear supernatants were pre- 
pared by a 5 min centrifugation at 1000 x g and either used immedi- 
ately or rapidly frozen in liquid nitrogen for storage at -80°C. To isolate 
synaptic vesicles, we loaded the supernatant from a 15 min centrifuga- 
tion at 10,000 x g above a 5 ml glycerol gradient (5%-25%) in buffer 
A. Synaptic vesicles were sedimented into the gradient during a 46 
min centrifugation at 55,000 rpm (287,000 x g) in an SW55 rotor and 
collected in 7-drop (350 ul) fractions from the bottom of the tube. Where 
indicated, the pooled synaptic vesicle peak included drops 40-58. 
lmmunoblotting of Subcellular Fractions 
Samples were prepared for electrophoresis by precipitation of gradient 
fractions in 10% trichloroaceticacid, 0.1 mglmldeoxycholate, washed 
in acetone, and resuspended in reducing sample buffer with 7 M urea 
for 15-30 min at 55OC. Homogenates were processed in parallel after 
concentration of membrane proteins by a Triton X-l 14 phase partition. 
After resolution on SDS-polyacrylamide (13%) gels, samples were 
transferred to PVDF (Immobilon-P; Millipore) membranes and probed 
with SVP-38 (anti-synaptophysin; Sigma) and KT3 MAbs using the 
ECL (Amersham) detection system. Endogenous VAMP-2 was de- 
tected using the 10.1 MAb (Baumert et al., 1989) and cellubrevin was 
detected with a rabbit polyclonal antibody (McMahon et al., 1993). 
Quantification of Synaptic Vesicle Targeting 
lmmunoblot band intensities werequantified bydensitometry(J. Loebl, 
Ephortec). By quantitating band intensities from an immunoblot of 
a serially diluted sample, it was established that this densitometry 
technique can produce linear readings over a lOOO-fold range of sam- 
ple concentrations. Multiple films with exposure times from 1 s to 2 
hr were scanned, and data from saturated or underexposed bands 
were disregarded. A quantitative measurement of the comparative 
efficiencies of targeting the VAMP-TAg mutants to synaptic vesicles 
was made by calculating a relative targeting index that incorporates 
corrections for the yield of synaptic vesicles by measuring the amount 
of synaptophysin in the peak fractions and for the total expression 
level of the mutant in each homogenate. Calculations for the targeting 
index were as follows: 
cDNA Constructions 
The rat VAMP-2 cDNA expression vector pRC-CMV-VAMP-2 was the 
gift of R. Scheller (Elferink et al., 1989). The VAMP cDNA was modified 
to create VAMP-TAg by insertion of complementary oligonucleotides 
between restriction endonuclease cleavage sites at the C-terminus of 
the coding region. In an initial construction, VAMP-TAgl, the KT3 
epitope SPPPEPET from the C-terminus of the SV40 large T antigen 
(MacArthur and Walter, 1984) was inserted between Aflll and Bsu361. 
[‘251]KT3 bound poorly to cells transfected with VAMP-TAgl, so a 
spacer region was inserted between the transmembrane domain and 
the SV40 T antigen sequences to improve the accessibility of the epi- 
tope. To provide an insertion site for the spacer, we introduced a Sacl 
site at the transmembrane-extracellular junction of VAMP-TAgl using 
the oligonucleotide TCGTTTACTTGAGCTCTTCACCTC to prime syn- 
thesis from a single-stranded VAMP-TAgl m13mp18 template. We 
inserted 13 amino acids, KGVEPKTYCYYSS, derived from the juxta- 
membrane region of the extracellular domain of the TfR, between the 
Sacl and Aflll sites. Tyr and Lys residues were added to this sequence 
to provide active sites for biochemical modification by membrane- 
impermeable reagents. In the TfR-TM chimera, the transmembrane 
domain of VAMP-TAg was replaced with the transmembrane domain 
of the transferrin receptor (McClelland et al., 1984) by inserting comple- 
mentary oligonucleotides between Bell and Sacl sites. Deletions and 
Ala scanning mutations were constructed by oligonucleotide-directed 
mutagenesis in ml3mpl8. 
Synaptic Vesicle Isolation 
Synaptic vesicles were isolated by a variation of the method of Clift- 
TI = Mutantr0.1/p38r01.1 
VAMP-TAgsvJp38svs 
VAMP-TAg,,llp38r,,.,, 
where TI is the targeting index, SVs are synaptic vesicles, total is the 
total protein in each homogenate, and p38 is synaptophysin. 
Transport of Antibody to Synaptic Vesicles 
KT3 MAb against the T antigen epitope tag was purified from serum- 
free hybridoma supernatant by protein G affinity chromatography and 
iodinated in aliquots of 100 ng with 1 mCi of Na-lZSI by the lodogen 
method (Pierce). Cells were incubated with 10’ cpmlml [‘251]KT3 for 
1 hr at 37OC in DME H-21, 5% BSA, 20 mM HEPES (pH 7.4) and 
then washed seven times at 4OC in PBS and BSA prior to isolation 
of synaptic vesicles as described above. rz51]KT3 was measured by 
counting 7-drop gradient fractions, without further processing, on a 
y-counter. Counts in each gradient fraction were normalized to the 
total count of cell-associated antibody. The synaptic vesicle peak in 
the gradient was detected by a well assay (Clift-C’Grady et al., 1990) 
modified for enzymaticdetection using horseradish peroxidase-conju- 
gated goat anti-mouse secondary antibodies and 0-phenylenediamine 
tablets (Zymed). 
In Vitro Assembly of SDS-Resistant SNARE Complexes 
Bacterially expressed recombinant proteins were purified using the 
glutathione S-transferase system as previously described (Calakos et 
al., 1994; Pevsner et al., 1994). Various combinations of soluble 
VAMP-2 (2.5 ng). syntaxin 1A (2 ng), and SNAP-25 (2.5 pg) (as indi- 
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cated in Figure 5A) were incubated overnight (16 hr) at 4°C in a final 
volume of 75 nl in 50 mM Tris (pH 8.0) 150 mM NaCI, 2.5 mM Car&, 
and 0.1% j3-mercaptoethanol. After adding 25 nl of sample buffer with 
120 mM DTT, samples were divided in half and either boiled or incu- 
bated at 37’C for 3 min. Samples were then resolved on SDS-poly- 
acrylamide (15%) gels and analyzed by immunoblotting with anti- 
syntaxin MAb (HPC-1) and polyclonal antibodies against VAMP-2 and 
SNAP-25 using a chemiluminescence detection system (DuPont-New 
England Nuclear). 
SNARE Complex lmmunoprecipitation 
Clarified lysates were prepared from transfected PC12 cells in Triton 
X-1001ysis buffer (10mM HEPES (pH 7.4],140mM potassiumacetate, 
2 mM MgC&, 0.1 mM EGTA, 2% Triton X-100). SNARE complexes 
were precipitated with protein A-agarose beads coated with anti- 
syntaxin (HPC-I) or anti-SNAP-25 (SMI-81) MAbs from lysates supple- 
mented with 0.1% gelatin and 0.1% BSA. Washed immunoprecipitates 
were resolved on nonreducing SDS-polyacrylamide gels (13%) and 
immunoblotted using the ECL detection system with an anti-VAMP-P- 
specific antiserum (Gaisano et al., 1994) and MAbs against syntaxin 
and SNAP-25. 
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